Clinical Trials · NCT02653391
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 22
- Start date
- Feb 2016
- Locations
- 2 sites, United States
- Primary endpoint
- Incidence and Severity of Ocular TEAEs.